nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—ADRA1D—Amitriptyline—migraine	0.359	0.434	CbGbCtD
Methoxamine—ADRA1B—Amitriptyline—migraine	0.261	0.316	CbGbCtD
Methoxamine—ADRA1A—Amitriptyline—migraine	0.206	0.249	CbGbCtD
Methoxamine—ADRA1B—GPCR ligand binding—CALCRL—migraine	0.000583	0.00336	CbGpPWpGaD
Methoxamine—ADRA1D—G alpha (q) signalling events—NPS—migraine	0.000581	0.00335	CbGpPWpGaD
Methoxamine—ADRA1D—G alpha (q) signalling events—TAC1—migraine	0.000581	0.00335	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000577	0.00332	CbGpPWpGaD
Methoxamine—ADRA1D—G alpha (q) signalling events—HTR2C—migraine	0.00057	0.00328	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000556	0.00321	CbGpPWpGaD
Methoxamine—ADRA1D—G alpha (q) signalling events—EDNRA—migraine	0.000555	0.0032	CbGpPWpGaD
Methoxamine—ADRA1B—LPA receptor mediated events—FOS—migraine	0.000547	0.00315	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000536	0.00309	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00052	0.003	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00052	0.003	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CALCRL—migraine	0.000518	0.00298	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—RAMP1—migraine	0.000518	0.00298	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000517	0.00298	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—HTR1D—migraine	0.00051	0.00294	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00051	0.00294	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000496	0.00286	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000494	0.00285	CbGpPWpGaD
Methoxamine—ADRA1B—G alpha (q) signalling events—TAC1—migraine	0.000482	0.00278	CbGpPWpGaD
Methoxamine—ADRA1B—G alpha (q) signalling events—NPS—migraine	0.000482	0.00278	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—HTR2B—migraine	0.000475	0.00273	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000474	0.00273	CbGpPWpGaD
Methoxamine—ADRA1B—G alpha (q) signalling events—HTR2C—migraine	0.000473	0.00273	CbGpPWpGaD
Methoxamine—ADRA1B—G alpha (q) signalling events—EDNRA—migraine	0.00046	0.00265	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000459	0.00265	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000456	0.00263	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000441	0.00254	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000432	0.00249	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000432	0.00249	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000429	0.00247	CbGpPWpGaD
Methoxamine—ADRA1A—G alpha (q) signalling events—NPS—migraine	0.000429	0.00247	CbGpPWpGaD
Methoxamine—ADRA1A—G alpha (q) signalling events—TAC1—migraine	0.000429	0.00247	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—HTR1D—migraine	0.000424	0.00244	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000423	0.00244	CbGpPWpGaD
Methoxamine—ADRA1A—G alpha (q) signalling events—HTR2C—migraine	0.00042	0.00242	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000412	0.00237	CbGpPWpGaD
Methoxamine—ADRA1A—G alpha (q) signalling events—EDNRA—migraine	0.000409	0.00236	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000406	0.00234	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—RAMP1—migraine	0.000397	0.00229	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CALCRL—migraine	0.000397	0.00229	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—HTR2B—migraine	0.000394	0.00227	CbGpPWpGaD
Methoxamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000393	0.00227	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000391	0.00225	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000386	0.00222	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000385	0.00222	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000385	0.00222	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000383	0.00221	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000383	0.00221	CbGpPWpGaD
Methoxamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000379	0.00218	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000378	0.00218	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—HTR1D—migraine	0.000376	0.00217	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000376	0.00217	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000367	0.00212	CbGpPWpGaD
Methoxamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000366	0.00211	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000366	0.00211	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CALCRL—migraine	0.000361	0.00208	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—RAMP1—migraine	0.000361	0.00208	CbGpPWpGaD
Methoxamine—ADRA1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000356	0.00205	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—HTR2B—migraine	0.00035	0.00202	CbGpPWpGaD
Methoxamine—ADRA1D—G alpha (q) signalling events—HTR2A—migraine	0.00035	0.00201	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000349	0.00201	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000337	0.00194	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000336	0.00194	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000331	0.00191	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—RAMP1—migraine	0.00033	0.0019	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CALCRL—migraine	0.00033	0.0019	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000325	0.00187	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000324	0.00187	CbGpPWpGaD
Methoxamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00032	0.00185	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00032	0.00184	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00032	0.00184	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000316	0.00182	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000313	0.00181	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000313	0.0018	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—HTR1B—migraine	0.000309	0.00178	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000305	0.00176	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000299	0.00172	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—RAMP1—migraine	0.000299	0.00172	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CALCRL—migraine	0.000299	0.00172	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—HTR1A—migraine	0.000298	0.00172	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—NPS—migraine	0.000293	0.00169	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—TAC1—migraine	0.000293	0.00169	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—RAMP1—migraine	0.000293	0.00169	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CALCRL—migraine	0.000293	0.00169	CbGpPWpGaD
Methoxamine—ADRA1B—G alpha (q) signalling events—HTR2A—migraine	0.00029	0.00167	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—HTR1D—migraine	0.000288	0.00166	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000288	0.00166	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—HTR2C—migraine	0.000288	0.00166	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000285	0.00164	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000284	0.00164	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000284	0.00164	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—EDNRA—migraine	0.00028	0.00161	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000278	0.0016	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000274	0.00158	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000271	0.00156	CbGpPWpGaD
Methoxamine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00027	0.00156	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—CALCA—migraine	0.000269	0.00155	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—HTR2B—migraine	0.000268	0.00155	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—RAMP1—migraine	0.000266	0.00153	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CALCRL—migraine	0.000266	0.00153	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HTR1D—migraine	0.000262	0.00151	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00026	0.0015	CbGpPWpGaD
Methoxamine—ADRA1A—G alpha (q) signalling events—HTR2A—migraine	0.000258	0.00149	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—HTR1B—migraine	0.000257	0.00148	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—HTR7—migraine	0.000252	0.00145	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—HTR1A—migraine	0.000247	0.00142	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000244	0.0014	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HTR2B—migraine	0.000244	0.0014	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—NPS—migraine	0.000243	0.0014	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—TAC1—migraine	0.000243	0.0014	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR1D—migraine	0.000239	0.00138	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—HTR2C—migraine	0.000239	0.00137	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—EDNRA—migraine	0.000232	0.00134	CbGpPWpGaD
Methoxamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000232	0.00133	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000231	0.00133	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—HTR1B—migraine	0.000228	0.00131	CbGpPWpGaD
Methoxamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000224	0.00129	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—CALCA—migraine	0.000223	0.00129	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR2B—migraine	0.000223	0.00128	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—HTR1A—migraine	0.000219	0.00126	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR1D—migraine	0.000217	0.00125	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—TAC1—migraine	0.000216	0.00125	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—NPS—migraine	0.000216	0.00125	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CALCRL—migraine	0.000213	0.00123	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—RAMP1—migraine	0.000213	0.00123	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR1D—migraine	0.000213	0.00123	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—HTR2C—migraine	0.000212	0.00122	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—HTR7—migraine	0.000209	0.0012	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—EDNRA—migraine	0.000206	0.00119	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR2B—migraine	0.000202	0.00116	CbGpPWpGaD
Methoxamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000199	0.00115	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—CALCA—migraine	0.000198	0.00114	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR2B—migraine	0.000198	0.00114	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR1D—migraine	0.000193	0.00111	CbGpPWpGaD
Methoxamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000192	0.00111	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—HTR7—migraine	0.000186	0.00107	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR2B—migraine	0.00018	0.00103	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—RAMP1—migraine	0.000177	0.00102	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CALCRL—migraine	0.000177	0.00102	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—HTR2A—migraine	0.000176	0.00102	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—HTR1B—migraine	0.000175	0.00101	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000171	0.000984	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—HTR1A—migraine	0.000168	0.000969	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—NPS—migraine	0.000166	0.000955	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—TAC1—migraine	0.000166	0.000955	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—HTR2C—migraine	0.000162	0.000936	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HTR1B—migraine	0.000159	0.000914	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—EDNRA—migraine	0.000158	0.000911	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—RAMP1—migraine	0.000157	0.000905	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CALCRL—migraine	0.000157	0.000905	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR1D—migraine	0.000155	0.000892	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HTR1A—migraine	0.000153	0.00088	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—CALCA—migraine	0.000152	0.000877	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—NPS—migraine	0.00015	0.000867	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—TAC1—migraine	0.00015	0.000867	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HTR2C—migraine	0.000148	0.00085	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—HTR2A—migraine	0.000146	0.000843	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR1B—migraine	0.000145	0.000836	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR2B—migraine	0.000144	0.000829	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—EDNRA—migraine	0.000144	0.000827	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—HTR7—migraine	0.000142	0.00082	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR1A—migraine	0.00014	0.000804	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CALCA—migraine	0.000138	0.000796	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—TAC1—migraine	0.000138	0.000792	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—NPS—migraine	0.000138	0.000792	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR2C—migraine	0.000135	0.000777	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR1B—migraine	0.000132	0.000759	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—EDNRA—migraine	0.000131	0.000756	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—HTR2A—migraine	0.00013	0.000749	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HTR7—migraine	0.000129	0.000745	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR1B—migraine	0.000129	0.000742	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR1D—migraine	0.000128	0.00074	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR1A—migraine	0.000127	0.000731	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LRP1—migraine	0.000127	0.00073	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CALCA—migraine	0.000126	0.000728	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—TAC1—migraine	0.000125	0.000719	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—NPS—migraine	0.000125	0.000719	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR1A—migraine	0.000124	0.000715	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR2C—migraine	0.000122	0.000706	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—NPS—migraine	0.000122	0.000704	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—TAC1—migraine	0.000122	0.000704	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR2C—migraine	0.00012	0.00069	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR2B—migraine	0.000119	0.000688	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—EDNRA—migraine	0.000119	0.000686	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR7—migraine	0.000118	0.00068	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR1B—migraine	0.000117	0.000674	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—EDNRA—migraine	0.000117	0.000671	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CALCA—migraine	0.000115	0.000661	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR1D—migraine	0.000114	0.000657	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR1A—migraine	0.000113	0.000649	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CALCA—migraine	0.000112	0.000646	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—NPS—migraine	0.000111	0.000639	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—TAC1—migraine	0.000111	0.000639	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR2C—migraine	0.000109	0.000627	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR7—migraine	0.000107	0.000618	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR2B—migraine	0.000106	0.000611	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—EDNRA—migraine	0.000106	0.00061	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LRP1—migraine	0.000105	0.000606	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR7—migraine	0.000105	0.000604	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CALCA—migraine	0.000102	0.000587	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—HTR2A—migraine	9.97e-05	0.000574	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NOTCH4—migraine	9.72e-05	0.00056	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR7—migraine	9.53e-05	0.000549	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR1B—migraine	9.38e-05	0.00054	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LRP1—migraine	9.34e-05	0.000538	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HTR2A—migraine	9.05e-05	0.000521	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR1A—migraine	9.02e-05	0.00052	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TAC1—migraine	8.89e-05	0.000512	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NPS—migraine	8.89e-05	0.000512	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PGR—migraine	8.89e-05	0.000512	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR2C—migraine	8.72e-05	0.000502	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EDNRA—migraine	8.48e-05	0.000488	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR2A—migraine	8.27e-05	0.000477	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NOTCH3—migraine	8.26e-05	0.000476	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CALCA—migraine	8.16e-05	0.00047	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NOTCH4—migraine	8.07e-05	0.000465	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR1B—migraine	7.78e-05	0.000448	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR7—migraine	7.63e-05	0.00044	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR2A—migraine	7.51e-05	0.000433	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR1A—migraine	7.49e-05	0.000432	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PGR—migraine	7.38e-05	0.000425	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TAC1—migraine	7.38e-05	0.000425	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NPS—migraine	7.38e-05	0.000425	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR2A—migraine	7.35e-05	0.000423	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR2C—migraine	7.23e-05	0.000417	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NOTCH4—migraine	7.16e-05	0.000413	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EDNRA—migraine	7.04e-05	0.000405	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR1B—migraine	6.91e-05	0.000398	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NOTCH3—migraine	6.86e-05	0.000395	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CALCA—migraine	6.77e-05	0.00039	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR2A—migraine	6.67e-05	0.000384	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR1A—migraine	6.65e-05	0.000383	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TGFBR2—migraine	6.57e-05	0.000379	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TAC1—migraine	6.55e-05	0.000378	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NPS—migraine	6.55e-05	0.000378	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PGR—migraine	6.55e-05	0.000378	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR2C—migraine	6.43e-05	0.00037	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR7—migraine	6.34e-05	0.000365	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EDNRA—migraine	6.25e-05	0.00036	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NOTCH3—migraine	6.09e-05	0.000351	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CALCA—migraine	6.02e-05	0.000347	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR7—migraine	5.63e-05	0.000324	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TGFBR2—migraine	5.46e-05	0.000314	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR2A—migraine	5.35e-05	0.000308	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TGFBR2—migraine	4.85e-05	0.000279	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ESR1—migraine	4.75e-05	0.000273	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR2A—migraine	4.44e-05	0.000256	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR2A—migraine	3.94e-05	0.000227	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ESR1—migraine	3.94e-05	0.000227	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ESR1—migraine	3.5e-05	0.000202	CbGpPWpGaD
